Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Advertisement intended for health care professionals

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
Latest Articles
- First Edition
- Latest Articles
Guidelines
Collections
Author Center
About

Skip Nav Destination

Update search

Querybuilder input 1 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 2 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 3 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 4 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 5 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

Querybuilder input 6 Querybuilder input

Filter

Title
Author
Full Text
Abstract
Keyword
DOI

NARROW

Publications

Filter by publications

Blood Advances (2)

Format

Filter by format

Journal Articles (2)

Subjects

Filter by subjects

Immunobiology and Immunotherapy (2)
Review Article (2)
Lymphoid Neoplasia (1)

Article Type

Filter by article-type

Review Article (2)

Topics

Close

Filter by topics

b-lymphocytes (2)
immunomodulation (2)
t-lymphocytes (2)
1-phosphatidylinositol 3-kinase (1)
adverse event (1)
animal model (1)
autoimmune diseases (1)
bcr-abl tyrosine kinase (1)
cancer (1)
chronic b-cell leukemias (1)

Date

Filter by date

Date range

Single date

From

To

Apply

Availability

Availability

1-2 of 2

immunomodulation

Sort by

Sort Order Select

Journal Articles

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19

Chaja F. Jacobs, Eric Eldering, Arnon P. Kater

Journal: Blood Advances

Blood Adv (2021) 5 (3): 913–925.

https://doi.org/10.1182/bloodadvances.2020003768

Published: 2021

Includes: Supplemental data

Journal Articles

Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia

Kamira Maharaj, Eva Sahakian, Javier Pinilla-Ibarz

Journal: Blood Advances

Blood Adv (2017) 1 (21): 1867–1875.

https://doi.org/10.1182/bloodadvances.2017006809

Published: 2017

Advertisement intended for health care professionals

Email alerts

Continuous Publishing Alert

New Journal Content Alert

Advertisement intended for health care professionals

Current Issue
Latest Articles
Collections

Community Conversations
Blood Advance Talks
All Issues

Newsroom
Copyright
Permissions

Submit to Blood Advances
Alerts
Contact Us

Order Reprints
Advertising in Blood Advances
Authors

Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Neoplasia
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright 2024 by American Society of Hematology

Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals